AGM/EGMMay 29, 2026, 02:22 PM
Eupraxia Pharmaceuticals to Hold Annual General Meeting on June 18
AI Summary
Eupraxia Pharmaceuticals Inc. announced its Annual General Meeting (AGM) of shareholders will be held virtually on June 18, 2026. Key items on the agenda include receiving and considering the audited financial statements for 2025 and 2024, setting the number of directors at seven, electing directors, and appointing KPMG LLP as the auditor. Shareholders of record as of May 8, 2026, are entitled to vote, with a proxy submission deadline of June 16, 2026.
Key Highlights
- Annual General Meeting (AGM) to be held virtually on Thursday, June 18, 2026, at 10:00 a.m. (Vancouver time).
- Shareholders will receive and consider audited financial statements for the years ended December 31, 2025 and 2024.
- Shareholders will vote to set the number of directors at seven and elect directors for the ensuing year.
- KPMG LLP, Chartered Professional Accountants, is nominated for appointment as auditor for the ensuing year.
- The record date for shareholders entitled to vote at the Meeting is May 8, 2026.
- Proxies must be received by TSX Trust Company by 10:00 a.m. (Vancouver time) on June 16, 2026.
Price Impact
More from EPRX